Analystreport

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Barclays PLC from $11.00 to $9.00.

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com